Isolation and characterization of a thymidylate synthase-deficient human colon tumor cell line

Biochemical Pharmacology

Volumn 58, Issue 10, 1999, Pages 1529-1537

  Hoganson, Diana K ^a   Williams, Angela W ^a   Berger, Sondra H ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Genetic complementation; Mutagenesis; Point mutation; Protein deficiency; Thymidine; Thymidylate synthase

Indexed keywords

THYMIDINE; THYMIDYLATE SYNTHASE;

ARTICLE; AUXOTROPHY; CELL LINE; CONTROLLED STUDY; HOMOZYGOSITY; HUMAN; HUMAN CELL; ISOELECTRIC FOCUSING; MUTAGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS;

CATALYSIS; CELL SEPARATION; COLONIC NEOPLASMS; GENETIC COMPLEMENTATION TEST; HUMANS; MUTATION, MISSENSE; STRUCTURE-ACTIVITY RELATIONSHIP; THYMIDINE; THYMIDYLATE SYNTHASE; TUMOR CELLS, CULTURED;

EID: 0032872004     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00237-3     Document Type: Article

References (39)

1. Carreras C.W., Santi D.V. The catalytic mechanism and structure of thymidylate synthase. Annu Rev Biochem. 64:1995;721-762.
2. Parker W.B., Cheng Y.C. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther. 48:1990;381-395.
3. Bapat A.R., Zarow C., Danenberg P.V. Human leukemic cells resistant to 5-fluoro-2′-deoxyuridine contain a thymidylate synthetase with lower affinity for nucleotides. J Biol Chem. 258:1983;4130-4136.
4. Jastreboff M.M., Kedzierska B., Rode W. Altered thymidylate synthetase in 5-fluorodeoxyuridine-resistant Ehrlich ascites carcinoma cells. Biochem Pharmacol. 32:1983;2259-2267.
5. Yoshioka A., Tanaka S., Hiraoka O., Koyama Y., Hirota Y., Ayusawa D., Seno T., Garrett C., Wataya Y. Deoxyribonucleoside triphosphate imbalance. J Biol Chem. 262:1987;8235-8241.
6. Dusenbury C.E., Davis M.A., Lawrence T.S., Maybaum J. Induction of megabase DNA fragments by 5-fluorodeoxyuridine in human colorectal tumor (HT29) cells. Mol Pharmacol. 39:1991;285-289.
7. Ayusawa D., Koyama H., Iwata K., Seno T. Selection of thymidine auxotrophic cell mutants defective in thymidylate synthase by their reduced sensitivity to methotrexate. Somat Cell Genet. 7:1981;523-534.
8. Li I.-C., Chu E.H.Y. Mutants of Chinese hamster cells deficient in thymidylate synthetase. J Cell Physiol. 120:1984;109-116.
9. Nussbaum R.L., Walmsley R.M., Lesko J.G., Airhart S.D., Ledbetter D.H. Thymidylate synthase-deficient Chinese hamster cells A selection system for the study of thymidylate synthase regulation and fragile X expression . Am J Hum Genet. 37:1985;1192-1205.
10. Houghton P.J., Germain G.S., Hazelton B.J., Pennington J.W., Houghton J.A. Mutants of human colon adenocarcinoma, selected for thymidylate synthase deficiency. Proc Natl Acad Sci USA. 86:1989;1377-1381.
11. Houghton J.A., Harwood F.G., Houghton P.J. Cell cycle control processes determine cytostasis or cytotoxicity in thymineless death of colon cancer cells. Cancer Res. 54:1994;4967-4973.
12. Houghton J.A., Harwood F.G., Tillman D.M. Thymineless death in colon carcinoma cells is mediated via Fas signaling. Proc Natl Acad Sci USA. 94:1997;8144-8149.
13. Barbour K.W., Hoganson D.K., Berger S.H., Berger F.G. A naturally occurring tyrosine to histidine replacement at residue 33 of human thymidylate synthase confers resistance to 5-fluoro-2′-deoxyuridine in mammalian and bacterial cells. Mol Pharmacol. 42:1992;242-248.
14. Tong Y., Liu-Chen X., Ercikan-Abali E.A., Capiaux G.M., Zhao S.-C., Banerjee D., Bertino J.R. Isolation and characterization of Thymitaq (AG337) and 5-fluoro-2-deoxyuridylate-resistant mutants of human thymidylate synthase from ethyl methanesulfonate-exposed human sarcoma HT1080 cells. J Biol Chem. 273:1998;11611-11618.
15. Houghton P.J., Rahman A., Will C.L., Dolnick B.J., Houghton J.A. Mutation(s) of the thymidylate synthase gene of human adenocarcinoma cells causes a thymidylate synthase-negative phenotype that can be attenuated by exogenous folates. Cancer Res. 52:1992;558-565.
16. Williams A.W., Dunlap R.B., Berger S.H. A hydroxyl group at residue 216 is essential for catalysis by human thymidylate synthase. Biochemistry. 37:1998;7096-7102.
17. Davis S.T., Berger S.H. Modulation of 5-fluoro-2′-deoxyuridine response by folinic acid in human colonic tumor cell lines The role of thymidylate synthase . Mol Pharmacol. 35:1989;422-427.
18. Takeishi K., Kanedo S., Ayusawa D., Shimizu K., Gotoh O., Seno T. Nucleotide sequence of a functional cDNA for human thymidylate synthase. Nucleic Acids Res. 13:1985;2035-2043.
19. Brattain M.G., Marks M.E., McCombs J., Finely W., Brattain D.E. Characterization of human colon carcinoma cell lines isolated from a single primary tumor. Br J Cancer. 47:1983;373-381.
20. Davis S.T., Berger S.H. Variation in human thymidylate synthase is associated with resistance to 5-fluoro-2′-deoxyuridine. Mol Pharmacol. 43:1993;702-708.
21. Berger S.H., Berger F.G. Thymidylate synthase as a determinant of 5-fluoro-2′-deoxyuridine response in human colonic tumor cell lines. Mol Pharmacol. 34:1988;474-479.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
23. Dev I.K., Dallas W.S., Ferone R., Hanlon M., McKee D.D., Yates B.B. Mode of binding of folate analogs to thymidylate synthase. J Biol Chem. 269:1994;1873-1882.
24. Hollestein M., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancers. Science. 253:1991;49-52.
25. Markowitz S., Wang J., Myeroff L., Parsons R., Sun L., Lutterbaugh J., Fan R.S., Zborowska E., Kinzler K.W., Vogelstein B., Brattain M., Willson J.K.V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science. 268:1995;1336-1338.
26. + tumor cells. Cell. 75:1993;1227-1236.
27. Umar A., Boyer J.C., Thomas D.C., Nguyen D.C., Risinger J.I., Boyd J., Ionov Y., Perucho M., Kunkel T.A. Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability. J Biol Chem. 269:1994;14367-14370.
28. Bhattacharyya N.P., Skandalis A., Ganesh A., Groden J., Meuth M. Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci USA. 91:1994;6319-6323.
29. Eshleman J.R., Lang E.Z., Bowerfind G.K., Parsons R., Vogelstein B., Willson J.K.V., Veigl M.L., Sedwick W.D., Markowitz S.D. Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer. Oncogene. 10:1995;33-37.
30. Meuth M. The structure of mutation in mammalian cells. Biochim Biophys Acta. 1032:1990;1-17.
31. Groden J., Nakamura Y., German J. Molecular evidence that homologous recombination occurs in proliferating human somatic cells. Proc Natl Acad Sci USA. 87:1990;4315-4319.
32. de Wind N., Dekker M., Berns A., Radman M., te Riele H. Inactivation of the mouse msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell. 82:1995;321-330.
33. Ashkenazi A., Dixit V.M. Death receptors Signaling and modulation . Science. 281:1998;1305-1308.
34. Dev I.K., Yates B.B., Leong J., Dallas W.S. Functional role of cysteine-146 in Escherichia coli thymidylate synthase. Proc Natl Acad Sci USA. 85:1988;1472-1476.
35. Michaels M.L., Kim C.W., Matthews D.A., Miller J.H. Escherichia coli thymidylate synthase Amino acid substitutions by suppression of amber nonsense mutations . Proc Natl Acad Sci USA. 87:1990;3957-3961.
36. Climie S., Ruiz-Perez L., Gonzalez-Pacanowski D., Prapunwattana P., Cho S.-W., Stroud R., Santi D.V. Saturation site-directed mutagenesis of thymidylate synthase. J Biol Chem. 265:1990;18776-18779.
37. Steadman D.J., Zhao P.-S., Spencer H.T., Dunlap R.B., Berger S.H. A structural role for glutamine 214 in human thymidylate synthase. Biochemistry. 37:1998;7089-7095.
38. Landis D.M., Loeb L.A. Random sequence mutagenesis and resistance to 5-fluorodeoxyuridine in human thymidylate synthase. J Biol Chem. 273:1998;25809-25817.
39. Johlin F.C., Swain E., Smith C., Tephly T.R. Studies on the mechanism of methanol poisoning Purification and comparison of rat and human liver 10-formyltetrahydrofolate dehydrogenase . Mol Pharmacol. 35:1989;745-750.